Gilbert Cisneros's ABT trades

  • The latest ABT trade was a purchase on Sep 18, 2026, when ABT closed at $102.61. It closed at $109.49 on Nov 3, 2026 (+7%).
  • 2 of the 3 ABT purchases we can price are higher today. The median one is +7%, against +1% for the S&P 500 over the same holding periods.

Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.

Gilbert Cisneros reported 6 ABT transactions in 6 filings with the House Clerk for 2025–2026: 3 purchases and 3 sales of Abbott Laboratories, with trade dates from Nov 18, 2025 to Sep 18, 2026. The median gap between trade date and filing date is 24 days, and every trade was reported within 45 days.

Transactions
6
Buys / sells
3 / 3
Disclosed range
$6K – $90K
Last filed
2026-10-12

ABT transactions reported by Gilbert Cisneros

6 of 6 rows
TypeOwner
Abbott Laboratories Common Stock
ABT
PurchaseSelf$1,001 - $15,0002026-10-12
#20035622
Abbott Laboratories Common Stock
ABT
PurchaseSelf$1,001 - $15,0002026-07-02
#20034906
Abbott Laboratories Common Stock
ABT
SaleSelf$1,001 - $15,0002026-06-08
#20034713
Abbott Laboratories Common Stock
ABT
SaleSelf$1,001 - $15,0002026-03-09
#20034144
Abbott Laboratories Common Stock
ABT
SaleSelf$1,001 - $15,0002026-01-12
#20033762
Abbott Laboratories Common Stock
ABT
PurchaseSelf$1,001 - $15,0002025-12-15
#20033619

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

How long disclosure took

Days from trade date to filing date for 6 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.

0–15 days
0
16–30 days
6
31–45 days
0
Over 45 days
0
Median / longest
24d / 27d

Source documents

6 House Clerk periodic transaction reports, newest first. Each link opens the official filing.

What Gilbert Cisneros's ABT filings don’t tell you

A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.

To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $39 a month.

Read the full research

Gilbert Cisneros and ABT: questions

Did Gilbert Cisneros buy or sell ABT?

House Clerk filings for 2025 and 2026 show 3 purchases and 3 sales of Abbott Laboratories (ABT) reported by Gilbert Cisneros, between 2025-11-18 and 2026-09-18. Reported owner: Self.

How much ABT did Gilbert Cisneros trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $6K – $90K across 6 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last ABT filing by Gilbert Cisneros?

The most recent filing that includes a ABT trade was filed on 2026-10-12. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Abbott Laboratories. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Gilbert Cisneros ABT disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.

$39/mo or $249/yr · cancel future renewals anytime · sources included